Novan to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
09 sept. 2020 08h05 HE
|
Novan, Inc.
- Live video webcast with President and CEO, Paula Brown Stafford, on Monday, September 14th at 4:00 PM EDT - MORRISVILLE, N.C., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or...
Novan Announces First Patient Enrolled and Dosed in B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum
03 sept. 2020 09h05 HE
|
Novan, Inc.
- Topline results targeted for Q2 2021, less than a year away - - SB206, if approved, has the potential to meet an important need for the treatment of molluscum, an area with no current FDA-approved...
Novan Initiates B-SIMPLE4 Pivotal Phase 3 Study of SB206 for Treatment of Molluscum
31 août 2020 08h05 HE
|
Novan, Inc.
- Clinical sites actively enrolling patients - - SB206, if approved, has the potential to meet an important need for the treatment of molluscum, an area with no current FDA-approved treatment - ...
Novan President and CEO, Paula Brown Stafford Named Chairman of the Board
28 juil. 2020 08h05 HE
|
Novan, Inc.
Expanded role of Ms. Stafford as Chairman reflects the Board’s confidence in her leadership of the Company and strategic direction Renowned pharmaceutical executive Robert Ingram retiring as Executive...
Novan to Host Live Audio Webcast of 2020 Annual Meeting of Stockholders
23 juil. 2020 08h05 HE
|
Novan, Inc.
MORRISVILLE, N.C., July 23, 2020 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2020 Annual...
Origin files patent application to protect its proposed treatment for viral and bacterial respiratory infections
24 mars 2020 07h00 HE
|
Origin
PRINCETON, N.J., March 24, 2020 (GLOBE NEWSWIRE) -- Origin, Inc., a Phase III clinical-stage biotechnology company, today announced that it has filed a provisional U.S. patent application to enhance...
Novan Announces Planned Chief Executive Officer Transition
18 déc. 2019 08h00 HE
|
Novan, Inc.
Paula Brown Stafford appointed as CEO effective February 2, 2020G. Kelly Martin’s term as CEO will end on February 1, 2020, per his employment contractMr. Martin will step down from the Novan Board of...
Novan Expands External Business Partner Network
19 juin 2019 08h15 HE
|
Novan, Inc.
Expansion of the existing relationship with MedPharm around formulation scienceManufacturing agreement established for production of proprietary drug substancePartner network now includes those...
Novan to Present Clinical Data at Annual Meeting of the Society for Investigative Dermatology
07 mai 2019 16h15 HE
|
Novan, Inc.
MORRISVILLE, N.C., May 07, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that recent data from the Company’s Phase 1b trial with SB414 cream for the...
Novan Completes Funding Transaction with Ligand Pharmaceuticals
06 mai 2019 09h00 HE
|
Novan, Inc.
Novan to immediately receive $12 million of non-dilutive capitalLigand to receive milestones and tiered royalty for North America SB206 molluscum indicationPhase 3 molluscum trial to begin recruitment...